Canada Funds New Glioblastoma Immunotherapy Research

Canadian scientists are testing a promising new approach to treat glioblastoma, one of the most aggressive and currently incurable brain cancers.

Brain Cancer Canada awarded $50,000 to Dr. Ian Lorimer and his team at Ottawa Hospital Research Institute to explore why glioblastoma tumors resist immunotherapy treatments that have revolutionized care for other cancers. The grant, announced in May 2026, will help test a drug that could change how the immune system responds to these deadly tumors.

Glioblastoma remains stubbornly resistant to modern treatments. While immunotherapy has dramatically improved survival rates for cancers like melanoma and lung cancer, it hasn't worked for brain cancer patients who face limited options and grim diagnoses.

Dr. Lorimer's research focuses on how glioblastoma cells hide from the immune system. His team is tracking immune cells within tumors and testing whether blocking certain immune responses could finally make immunotherapy effective for these patients.

"Glioblastoma is currently an incurable disease with very limited treatment options," Dr. Lorimer says. "Our grant will test a novel immunotherapy approach, hopefully providing a new and effective treatment for glioblastoma patients."

The research hits close to home for Dr. Lorimer, whose colleague was recently diagnosed with the disease. "We can stop this disease, but it takes a team," he says.

The Ripple Effect

This grant represents one piece of a larger investment in hope. Brain Cancer Canada awarded six grants totaling $425,000 during Brain Cancer Awareness Month, all funded through community golf tournaments and donations.

Two memorial tournaments made this research possible. Julie Villamere organized one in memory of her daughter Andrea, who died from brain cancer at age 27 in 2023. Esther Seaman hosts another honoring her late husband JP Leclerc, who also lost his battle with glioblastoma.

"Thank you to Brain Cancer Canada and the incredible doctors advancing research. Your work brings light to families facing the unimaginable," says Villamere, who found support and purpose through the charity while navigating her grief.

Since 2015, Brain Cancer Canada has directed nearly $3 million to 31 research projects across the country. As a fully volunteer-run organization, every donated dollar goes directly to research.

Early experiments suggest Dr. Lorimer's approach could work, and the data from this project will determine whether a clinical trial can move forward. Families facing glioblastoma diagnoses finally have another reason to hope.